Ann Arbor Digital Devices’ A2D2 1713-Motion, a direct digital X-ray, motion and/or still image retrofit system, is compatible with most medical X-ray generators including single phase and three phase, standard and high-frequency X-ray machines.

Multicenter Trial BI-RADS 3 Breast Lesions Low Cancer Rate

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as ‘probably benign’ on supplemental screening ultrasound could be re-evaluated with imaging in 12 months, reducing patient anxiety, follow-up exams and unnecessary biopsies. Results of the study are published online in the journal Radiology.

Adopting an approach that encourages continued progress while simultaneously acknowledging short-term obstacles, the Healthcare Information and Management Systems Society (HIMSS) recommends launching Stage 2 Meaningful Use on-schedule and extending Year 1 of the Meaningful Use Stage 2 attestation period through April 2015 and June 2015 for eligible hospitals (EHs) and eligible professionals (EPs), respectively.  This would encompass 18 months in which EHs and EPs can attest to Meaningful Use requirements for one quarter.

Users of linear accelerator, Versa HD, can now bring target immobilization to new levels through automated gating with Active Breathing Coordinator. For anatomies affected by respiratory motion, such as lung, liver and breast, Active Breathing Coordinator provides non-invasive, internal immobilization of the target, triggering radiation delivery when anatomy is immobilized.

Baptist Health eliminated 85 percent of CDs by storing and sharing medical images in real-time through Accelarad’s secure cloud platform. As central Alabama’s healthcare leader and one of only five Level II trauma facilities in the state, Baptist Health has been an Accelarad customer since March 2013.

 

Frost & Sullivan has named Siemens Healthcare the "2013 North American Interventional Radiology Company of the Year" for its interventional imaging solutions in cardiology, radiology and hybrid surgery. The Frost & Sullivan study states, "Siemens is extremely well positioned within the interventional cardiology segment, within the overarching surgical clinical segment, as well as neurology, oncology and pediatrics." 

Siemens says it has been able to sustain market expansion momentum by continually leading the industry in the development of new technology for high-end interventional equipment, while enhancing current clinical applications and enabling new ones. Over the last decade, Siemens said it has succeeded in establishing the company as the market and technology leader in the United States by exploring new possibilities to enhance interventional therapy and patient care. 

August 22, 2013 — Hologic Inc. announced the commercialization of Horizon, a redesigned DXA (dual-energy X-ray absorptiometry) imaging system for the assessment of three critical health problems — osteoporosis, cardiovascular disease and obesity.

Horizon DXA imaging system

August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now